Projects per year
Personal profile
Education
- 1994.09-2002.08 Ph.D., Graduate Institute of Life Science, National Defense Medical Center
- 1991-1993 M.S., Department of Aquaculture, National Taiwan Ocean University
- 1984-1988 B.S., Department of Aquaculture, National Taiwan Ocean University
Experience
- 2018.03- Director, Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University
- 2017.08- Professor, Master Program fro Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2016.08-2019.01 Director, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2014.08- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.08- Professor, Department of Physiology, School of Medicine, Taipei Medical University
- 2011.08-2014.07 Associated Professor, Department of Physiology, School of Medicine, Taipei Medical UniversityDepartment of Physiology
- 2010.02-2011.07 Associated professor, Master Program/Ph.D. Program in Pharmacology and Toxicology, Tzu Chi University
- 2006.02-2010.02 Assistant professor, Master Program/Ph.D. Program in Pharmacology and Toxicology, Tzu Chi University
- 2005.08-2006.02 Postdoctoral Researcher, Academia Sinica
- 2004.02-2005.07 Assistant professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 2003.08-2004.02 Postdoctoral Researcher, Institute of Biomedical Sciences, Academic Sinica
- 2002.08-2003.07 Manger, Department of Research and Development
Related Link
Research Interests
- Renolpathology
- molecular biology
- Renal pathophysiology animal model
Fingerprint
Dive into the research topics where Heng Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting the Adipokines/Batokines Secreted from Afferent Renal Artery Adipocyte Tissue to Explore the Obesity Induced Diabetic Renal Pathophysiology Role under Atf3 Regulation and the Basic and Clinical Therapeutic Application. (1/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
發展一新型藥物作為改善肥胖及肥胖引發糖尿病導致腎病變症候群之轉譯醫學研究(3/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
發展一新型藥物作為改善肥胖及肥胖引發糖尿病導致腎病變症候群之轉譯醫學研究(2/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
Development of a New Drug as a Translational Medical Study to Improve the Obesity and Obesity-Induced Diabetes Nephropathy Syndrome
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
可攜式急性腎臟損傷 (AKI)及顯影劑腎病變(CIN)尿液微型核醣核酸的非侵入式檢測系統之發展及開發單一化學藥物治療AKI及CIN所造成之腎損傷(1/3)
5/1/17 → 4/30/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Exploration and biological evaluation of 7-methoxy-3-methyl-1H-chromeno[4,3-c]pyrazol-4-one as an activating transcription factor 3 inducer for managing metabolic syndrome
Chang, Y. H., Lin, H., Li, H. F., Chen, H. H. & Hung, H. Y., Jan 15 2023, In: European Journal of Medicinal Chemistry. 246, 114951.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Emergent Roles of Circular RNAs in Metabolism and Metabolic Disorders
Wu, Y. L., Li, H. F., Chen, H. H. & Lin, H., Feb 1 2022, In: International journal of molecular sciences. 23, 3, 1032.Research output: Contribution to journal › Review article › peer-review
Open Access7 Citations (Scopus) -
Role of PVAT in obesity-related cardiovascular disease through the buffering activity of ATF3
Li, H. F., Liu, H. T., Chen, P. Y., Lin, H. & Tseng, T. L., Dec 22 2022, In: iScience. 25, 12, 105631.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Salvia miltiorrhiza Extract and Individual Synthesized Component Derivatives Induce Activating-Transcription-Factor-3-Mediated Anti-Obesity Effects and Attenuate Obesity-Induced Metabolic Disorder by Suppressing C/EBPα in High-Fat-Induced Obese Mice
Wu, Y. L., Lin, H., Li, H. F., Don, M. J., King, P. C. & Chen, H. H., Mar 1 2022, In: Cells. 11, 6, 1022.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Hyperpolyploidization of hepatocyte initiates preneoplastic lesion formation in the liver
Lin, H., Huang, Y. S., Fustin, J. M., Doi, M., Chen, H., Lai, H. H., Lin, S. H., Lee, Y. L., King, P. C., Hou, H. S., Chen, H. W., Young, P. Y. & Chao, H. W., Dec 2021, In: Nature Communications. 12, 1, p. 645 645.Research output: Contribution to journal › Article › peer-review
Open Access25 Citations (Scopus)